scholarly journals An immunological study of the pili ofPseudomonas aeruginosa

1975 ◽  
Vol 74 (3) ◽  
pp. 419-430 ◽  
Author(s):  
D. E. Bradley ◽  
T. L. Pitt

SUMMARYAn attempt was made to correlate serological relationships determined by the pili, the flagella and the O-somatic antigens ofPseudomonas aeruginosa, and to make a preliminary assessment of use of the pilus antigen as an epidemiological marker. A method is described for the preparation of antiserum specific for the ‘normal’ PSA pili ofP. aeruginosa.A high titre of pilus antibodies was obtained by immunizing rabbits with mutants whose pili had lost their ability to retract into the cell. The ‘normal’ form of the organism, with retractile pili, was poorly agglutinated by high-titre anti-pilus serum, but suspensions of it that had been treated with osmium tetroxide showed greatly increased agglutinability. Antibody labelling for electron microscopy was used to determine the serological relations of pili and of flagella forP. aeruginosastrains belonging to different serological groups as defined by O-somatic antigens. The distribution of pilar and flagellar antigens among strains was not correlated with the O-somatic serotype. A strain ofP. aeruginosacarrying a drug-resistance plasmid had fewer ‘normal’ PSA pili than the background strain.Pseudomonas aeruginosanormally possesses thin polar pili (fimbriae) which constitute one of the classes of heat-labile antigens of the organism. A previous study of the flagellar antigens (Pitt & Bradley, 1975), which are also heat-labile, was an essential preliminary to the development of a useful typing system based on heat-labile antigens. The present work extends this to the pilus antigens. The principle object is to define serological differences determined by pili, flagella, and heat-stable O-somatic antigens. In order to make this comparison, it has been necessary to develop a method for preparing specific antisera against pili, free from flagellar and O-somatic antibodies.Many studies have been made ofP. aeruginosapili; two basic types of pili have so far been established: (1) the ‘normal’ polar pili mentioned above (Bradley, 1966), to be called PSA pili for convenience and (2) the non-polar pili determined by the intergeneric P-group drug-resistance plasmid RP1, called RP1 pili (Bradley, 1974a; C. H. To & C. C. Brinton, in preparation). Non-polar pili have also been found in association with theP. aeruginosa-specific drug-resistance plasmid R130 (L. E. Bryan, University of Alberta, Canada, personal communication), but they are still under study and little is known about them. Since the present work is principally aimed at evaluating the usefulness of pilus antigens as serological markers, emphasis has been placed on PSA pili, though obviously the presence of R-factor-determined pili cannot be ignored.There are two ways of observing the serological relationships of bacterial appendages such as pili: either qualitatively by the direct observation of adsorbed antibodies in the electron microscope (Lawn, 1967), or quantitatively by conventional agglutination tests. In this work we have used the first method to define different serological types of pilus, and the second to study in detail the reactions of antibodies specific to the pilus.Although the injection into rabbits of formolized suspensions ofP. aeruginosaresults in the formation of flagellar antibody in high titre, the antibody response to the pili is poor (Pitt & Bradley, 1975). The pilus is in the form of a long thin filament consisting of polymerized pilus protein or pilin. It has been demonstrated (Bradley, 1972a) that under certain influences, such as chemical action or bacteriophage adsorption (see below), the filaments withdraw into the cell, the pilin probably being depolymerized by a mechanism at the base. CertainP. aeruginosamutants that lack the ability to retract their pili (Bradley, 1972a, 1974b) have many more filaments than do normal strains. We now show that these mutants are valuable in producing high-titre antiserum. Other mutants without pili have been isolated (Bradley, 1972b), and absorption of sera with these organisms removes antibodies to other components of the cell.Certain bacteriophages useP. aeruginosapili as receptors (Bradley, 1966, 1973a, b, 1974a; Bradley & Pitt, 1974). One aspect of the present work has been to determine whether the phage-sensitivity pattern varies with pili of different serological types.

1977 ◽  
Vol 30 (4) ◽  
pp. 345 ◽  
Author(s):  
GP White ◽  
NW Dunn

The TOL catabolic plasmid was shown to be compatible with the R91 drug resistance plasmid. However, the TOL plasmid was extremely unstable in mutant PA03 of P. aeruginosa. By selecting for stabilization of the TOL plasmid in PA03 harbouring R91, it was possible to isolate a strain in which markers from both R91 and TOL appeared to exist in a single recombinant plasmid. This plasmid, pND3, encoded resistance to carbenicillin, was able to transfer at the same frequency as the R91 plasmid and encoded the ability to grow on m-toluate, p-toluate, m-xylene, p-xylene and toluene. In addition, it was shown to be incompatible with the NAH catabolic plasmid and it could be transferred by transduction. The TOL plasmid could stabilize in PA03 harbouring R91 without fusion with R91, and could stabilize in PA03 in the absence of R91. PA03 harbouring either the recombinant plasmid or the stable TOL plasmid in the absence of R91 could promote bacterial chromosome transfer between mutant derivatives of P. aeruginosa strain P AO.


2021 ◽  
Vol 16 (1) ◽  
pp. 1934578X2098774
Author(s):  
Jinpeng Zou ◽  
Yang Liu ◽  
Ruiwei Guo ◽  
Yu Tang ◽  
Zhengrong Shi ◽  
...  

The drug resistance of Pseudomonas aeruginosa is a worldwide problem due to its great threat to human health. A crude extract of Angelica dahurica has been proved to have antibacterial properties, which suggested that it may be able to inhibit the biofilm formation of P. aeruginosa; initial exploration had shown that the crude extract could inhibit the growth of P. aeruginosa effectively. After the adaptive dose of coumarin was confirmed to be a potential treatment for the bacteria’s drug resistance, “coumarin-antibiotic combination treatments” (3 coumarins—simple coumarin, imperatorin, and isoimperatorin—combined with 2 antibiotics—ampicillin and ceftazidime) were examined to determine their capability to inhibit P. aeruginosa. The final results showed that (1) coumarin with either ampicillin or ceftazidime significantly inhibited the biofilm formation of P. aeruginosa; (2) coumarin could directly destroy mature biofilms; and (3) the combination treatment can synergistically enhance the inhibition of biofilm formation, which could significantly reduce the usage of antibiotics and bacterial resistance. To sum up, a coumarin-antibiotic combination treatment may be a potential way to inhibit the biofilm growth of P. aeruginosa and provides a reference for antibiotic resistance treatment.


2009 ◽  
Vol 13 ◽  
pp. S52
Author(s):  
Lie Huang ◽  
Qin Hu ◽  
Runxiang Wu ◽  
Dongmei Zeng ◽  
Xuedong Lu

1966 ◽  
Vol 12 (2) ◽  
pp. 231-241 ◽  
Author(s):  
Robert A. Altenbern

Hemolysin is formed in sonic extracts of cells of Pseudomonas aeruginosa by the action of a heat-labile substance, probably an intracellular "release" enzyme, on a substrate from the disrupted cell. The substrate and most of the hemolysin released can be sedimented by high-speed centrifugation. Hemolysin-negative strains appear to possess no release enzyme but do contain the substrate since addition of particulate matter to extracts of hemolysin-positive cells increases the rate and extent of hemolysin formation. The rate of hemolysin release in sonic extracts is strongly influenced by the concentration of the two reactants, and minor dilution abolishes all activity. There is only a small amount of release enzyme and substrate present in 24-h cells but increasingly greater amounts appear in extracts of 48- and 72-h cells. The hemolysin-forming system is sensitive to heat and is inactivated in 2 min at 100°. Treatment of particulate matter with lysozyme plus EDTA does not reduce the amount of hemolysin released by subsequent exposure of the particles to the release enzyme present in fresh sonic extract.


Chemotherapy ◽  
1997 ◽  
Vol 43 (5) ◽  
pp. 323-331 ◽  
Author(s):  
Miyuki Hasegawa ◽  
Intetsu Kobayashi ◽  
Takeshi Saika ◽  
Minoru Nishida

Author(s):  
Syed S. Ameen ◽  
Shanmukananda Prakash ◽  
Laxminarayana Bairy K. ◽  
Shahabuddin Soherwardi

Background: Pseudomonas aeruginosa, a gram-negative pathogen commonly associated with nosocomial infections is the most widespread multidrug-resistant pathogen causing pneumonia in hospitalized patients. Inadequate empirical therapy has been associated with high mortality and morbidity. Objective: To evaluate and analyze the antimicrobial susceptibility pattern of P. aeruginosa in respiratory infections in a tertiary care hospital.Methods: The study was carried out at Kasturba Hospital, Manipal from Jan 2011 to Dec 2011. Specimens of 63 in-patients were analyzed who were culture positive for P. aeruginosa.Results: Majority of patients were aged above 40yrs with a male preponderance. Specimens were taken from patients who were diagnosed with bronchiectasis, pneumonia, COPD, bronchial asthma etc. Overall the organism was most sensitive to carbapenems (87.3%) followed by cefoperazone-sulbactam combination (85.7%). Sensitivity to ceftazidime and cefepime was equal (82.5%) and was more when compared to piperacillin-tazobactam (81.5%). Overall resistance rate was highest for fluoroquinolones (23.8%) followed by aztreonam (22.2%).Conclusions: Hence we would like to recommend cefoperazone-sulbactam as the preferred antipseudomonal agent and carbapenems as reserved drugs in treating pseudomonal lung infections. Use of fluoroquinolones and aztreonam as monotherapy in resistant P. aeruginosa infections should be restricted.


1983 ◽  
Vol 39 (2) ◽  
pp. 970-973 ◽  
Author(s):  
M. Lourdes M. Silva ◽  
Isabel C. A. Scaletsky ◽  
M. Henriqueta L. Reis ◽  
M. Heloiza T. Affonso ◽  
Luiz R. Trabulsi

Sign in / Sign up

Export Citation Format

Share Document